
Ilumivu, founded in 2009, is a digital therapeutics company that provides personalized early condition detection and management solutions. They offer mobile and web applications integrated with wearable sensors to enable connected health for behavioral health researchers and clinical care organizations. Their mission is to empower users, clinicians, and researchers with actionable information. The company's ivu platform combined with mEMA (mobile EMA) captures rich, multimodal behavioral data streams through user engagement, facilitating deeper understanding between patients and providers and improving clinical outcomes. Ilumivu's software supports health plans in early identification and pre-diagnosis of conditions like hypertension and diabetes using data from smartwatches and machine learning algorithms. For healthcare delivery, it enables automated early intervention and remote monitoring based on patient baselines. Researchers leverage the system for ecological momentary assessment (EMA) and just-in-time adaptive interventions (JITAI), with a proven track record in over 100 clinical research settings and dozens of NIH and NSF-funded studies. Ilumivu is trusted by over 70 health systems and universities.

Ilumivu, founded in 2009, is a digital therapeutics company that provides personalized early condition detection and management solutions. They offer mobile and web applications integrated with wearable sensors to enable connected health for behavioral health researchers and clinical care organizations. Their mission is to empower users, clinicians, and researchers with actionable information. The company's ivu platform combined with mEMA (mobile EMA) captures rich, multimodal behavioral data streams through user engagement, facilitating deeper understanding between patients and providers and improving clinical outcomes. Ilumivu's software supports health plans in early identification and pre-diagnosis of conditions like hypertension and diabetes using data from smartwatches and machine learning algorithms. For healthcare delivery, it enables automated early intervention and remote monitoring based on patient baselines. Researchers leverage the system for ecological momentary assessment (EMA) and just-in-time adaptive interventions (JITAI), with a proven track record in over 100 clinical research settings and dozens of NIH and NSF-funded studies. Ilumivu is trusted by over 70 health systems and universities.
Founded: 2009
Headquarters: Asheville, North Carolina
Product: Digital therapeutics / connected health platform using smartphone and wearable data
Use cases: Clinical research (EMA, JITAI) and remote patient monitoring
Investors: Series A led by Health Catalyst Capital; Pisgah Fund participated
Behavioral health, chronic disease monitoring, and clinical research data collection and intervention delivery.
2009
Digital health / Digital therapeutics
Announced alongside acquisition of Cardiogram; Pisgah Fund participated.
“Series A led by Health Catalyst Capital with participation from Pisgah Fund”